Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Invera Medical Limited |
| Country | Ireland |
| Start Date | Oct 01, 2022 |
| End Date | Sep 30, 2024 |
| Duration | 730 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190175560 |
Chronic venous disease is one of the most common diseases in the developed world, affecting up to 60% of adults over the age of 50.
Chronic venous disease is the leading cause of Venous Leg Ulcers which are chronic open sores, usually on the inside of the leg that will not heal without specialist treatment.
The total costs associated with managing venous disease patients across Europe and the US is 33.4 billion per year, representing 2.5% of total healthcare expenditure.Most patients are treated with ineffective compression bandaging which does not treat the underlying cause and has an unacceptably high recurrence rate.
These bandages are also sent to landfill with a high environmental impactEnVena is the worlds first device to mimic the bodys natural healing response to deliver an effective treatment to venous leg ulcer patients.
Invera Medical Limited
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant